Skip to main content

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Replimune Group, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of REPL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders1672175+10
Shares82.0M27.8K81.0M−989.0K (−1.2%)
Value$799.3M$271.4K$752.1M−$46.9M (−5.9%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Replimune Group, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to REPL in Q2 2025
InstitutionSharesValue% of portfolio
Ally Bridge Group (NY) LLC528,491$4.91M4.09%
Nan Fung Trinity (HK) Ltd465,527$4.32M0.52%
Sectoral Asset Management Inc231,650$2.15M1.42%
Readystate Asset Management LP187,720$1.74M0.07%
Candriam Luxembourg S.C.A.171,527$1.59M0.01%
ExodusPoint Capital Management, LP157,550$1.46M0.02%
Ameriprise Financial Inc154,212$1.43M0.00%
Saturn V Capital Management LLC128,917$1.20M0.49%
HRT Financial LP91,175$847.0K0.00%
Centiva Capital, LP74,253$689.8K0.05%
Encompass More Asset Management66,730$619.9K0.15%
XTX Topco Ltd62,794$583.4K0.02%
Brevan Howard Capital Management LP58,242$541.1K0.01%
LMR Partners LLP50,000$464.5K0.01%
Los Angeles Capital Management LLC43,422$403.4K0.00%
Glenmede Investment Management, LP25,650$238.3K0.00%
TCG Advisory Services, LLC25,367$235.7K0.01%
Group One Trading, L.P.19,723$183.2K0.01%
LPL Financial LLC16,344$151.8K0.00%
Verition Fund Management LLC15,761$146.4K0.00%
Aigen Investment Management, LP13,411$124.6K0.02%
Oxford Asset Management LLP13,406$124.5K0.04%
Quadrature Capital Ltd12,671$117.8K0.00%
Letko, Brosseau & Associates Inc10,800$100.3K0.00%
Sherbrooke Park Advisers LLC10,735$99.7K0.04%
ADAR1 Capital Management, LLC10,400$96.6K0.02%
Raymond James Financial Inc7,414$68.9K0.00%
Point72 (DIFC) Ltd4,654$43.2K0.00%
Jones Financial Companies LLLP3,185$29.7K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.537$5.00K0.00%
Riggs Asset Managment Co. Inc.91$8460.00%
Hughes Financial Services, LLC62$3410.00%
Principal Securities, Inc.26$2420.00%

Sold out (23)

Institutions that held Replimune Group, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (2)

Institutions that held Replimune Group, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding REPL in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Glenmede Trust Co NA25,917$252.7K
Lindbrook Capital, LLC1,917$18.7K